Alkem Laboratories Limited has informed the Exchange regarding a press release dated March 21, 2026, titled "Alkem Laboratories launches Semaglutide injection in India, with weekly therapy starting at INR 450/- ".
Press Release Mar 21 2026
Earlier from Alkem Laboratories
- Press Release Mar 20 2026
- Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Alkem Laboratories Ltd.
- Press Release Feb 13 2026
- Press Release Jan 08 2026